Summary Aragon Pharmaceuticals, Inc. (Aragon) is a biopharmaceutical company. The company develops small-molecule drugs for the treatment of hormone-dependent cancers, such as prostate and breast cancer. Its programs include ARN-509 clinical program, SERO program and SARD program. Aragon’s drug candidate -509 Clinical Programs is selective androgen receptor degraders programs and selective estrogen receptor degraders Programs. The company develops anti hormonal cancer therapies to treat hormone dependent cancers, such as tumors, prostate and breast cancer. It discovers and develops new small molecule therapeutics. The company’s investors include The Column Group and Orbimed Advisors, LLC. Aragon is headquartered in San Diego, California, the US. In June 2013, Johnson & Johnson, entered into an agreement to acquire Aragon, for purchase consideration $1000m. Aragon Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five... Research Beam Model: Research Beam Product ID: 128998 250 USD New
Aragon Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Aragon Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Pharmaceuticals
  • Published On : July   2014
  • Pages : 24
  • Publisher : GlobalData
 
 
 
Summary

Aragon Pharmaceuticals, Inc. (Aragon) is a biopharmaceutical company. The company develops small-molecule drugs for the treatment of hormone-dependent cancers, such as prostate and breast cancer. Its programs include ARN-509 clinical program, SERO program and SARD program. Aragon’s drug candidate -509 Clinical Programs is selective androgen receptor degraders programs and selective estrogen receptor degraders Programs. The company develops anti hormonal cancer therapies to treat hormone dependent cancers, such as tumors, prostate and breast cancer. It discovers and develops new small molecule therapeutics. The company’s investors include The Column Group and Orbimed Advisors, LLC. Aragon is headquartered in San Diego, California, the US.
In June 2013, Johnson & Johnson, entered into an agreement to acquire Aragon, for purchase consideration $1000m.

Aragon Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Aragon Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 5
Aragon Pharmaceuticals, Inc., Pharmaceuticals & Healthcare Deals By Type, 2008 to YTD 2014 6
Aragon Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014 7
Aragon Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014 8
Aragon Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2008 to YTD 2014 9
Aragon Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Aragon Pharma Raises US$50 Million In Series D Financing 10
Aragon Pharma Raises US$42 Million In Series C Financing 12
Aragon Pharma Raises US$22 Million In Series B Financing 14
Farallon Biosciences Secures US$4 Million In Venture Financing 16
Aragon Pharma Secures US$8 Million In Series A Financing 17
Acquisition 18
Johnson & Johnson Completes Acquisition Of Aragon Pharma For US$1 Billion 18
Aragon Pharmaceuticals, Inc. - Key Competitors 21
Key Employees 22
Locations And Subsidiaries 23
Head Office 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24
List Of Tables
List of Tables
Aragon Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Key Facts 1
Aragon Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 1
Aragon Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014 1
Aragon Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014 1
Aragon Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 5
Aragon Pharmaceuticals, Inc., Pharmaceuticals & Healthcare Deals By Type, 2008 to YTD 2014 6
Aragon Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014 7
Aragon Pharmaceuticals, Inc., Deals By Therapy Area, 2008 to YTD 2014 8
Aragon Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2008 to YTD 2014 9
Aragon Pharma Raises US$50 Million In Series D Financing 10
Aragon Pharma Raises US$42 Million In Series C Financing 12
Aragon Pharma Raises US$22 Million In Series B Financing 14
Farallon Biosciences Secures US$4 Million In Venture Financing 16
Aragon Pharma Secures US$8 Million In Series A Financing 17
Johnson & Johnson Completes Acquisition Of Aragon Pharma For US$1 Billion 18
Aragon Pharmaceuticals, Inc., Key Competitors 21
Aragon Pharmaceuticals, Inc., Key Employees 22
List Of Figures
List of Figures
Aragon Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014 1
Aragon Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 5
Aragon Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014 6
Aragon Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014 7
Aragon Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014 8
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter